RFK Jr. Wants to Cut Back on Psychiatric Medication Prescriptions

A new initiative by the federal government is aiming to reduce the use of psychiatric medications, replacing them with alternative treatments. Here is a look at the plan, as well as what health experts are saying about the strategy.

MAHA Plan to Reduce Reliance on Psychiatric Medications Draws Mixed Reviews

U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. announced a new plan to reduce “overprescribing” of psychiatric medications. The plan is also intended to support alternative treatment options. Kennedy announced the strategy on Monday at a MAHA Institute summit on the topic of mental health and overmedicalization.

Monday's announcement came after the release of similar guidelines by a number of psychiatry groups. For example, the American Society of Clinical Psychopharmacology issued new guidelines in February with a goal of supporting more research and training on when some medications should be discontinued.

While many psychiatry experts agree with the federal efforts of boosting access to psychiatric healthcare with more options, some medical professionals are raising concerns about the emphasis on moving away from traditional medications in a time when access to mental health resources is still inadequate.

Kennedy has made the reduced usage of psychiatric medications a key tenet of his "Make America Healthy Again" movement. The secretary has put a particular emphasis on antidepressants, claiming that they are overused and could be linked with the increase in violence and mass shootings over the last few decades. Kennedy has also raised concerns that the reliance on these types of prescribed medications also presents risks to developing fetuses when taken during pregnancy.

While there have been some scientifically documented cases of these risks, the U.S. Food and Drug Administration (FDA) maintains that the drugs are generally safe and effective. Common conditions treated by these types of psychiatric drugs include anxiety, depression, obsessive-compulsive disorder, substance use disorder, and eating disorders.

Overprescribing is a term used to describe the tendency of some clinicians to prescribe medications to individuals who may not need them. The common line of thought is that some of the symptoms could be treated with nonmedication interventions that do not come with the same degree of side effects. The concept of overprescribing also refers to patients taking medications that are no longer effective for them.  

Similarly, "deprescribing" means that it makes sense to discontinue the use of a medication if it is not effective or if the patient is experiencing side effects that outweigh the efficacy. In that case, it often makes more sense to deprescribe the current medication and replace it with a different type of treatment.

Antibiotics are a common type of medication that have been thrown in the spotlight in recent years as many healthcare providers warn that it is being prescribed too frequently. There is a chance that a patient could develop a tolerance to antibiotics if their use is not judicious. This is also the case with some types of antidepressants and antipsychotics.

According to a news release from HHS, the various agencies under the governing body plan to work in a concerted effort to “evaluate prescription patterns for psychiatric medications, their benefits and potential harms, and elevate the role of nonmedication treatments and scalable, evidence-based solutions to improve mental health.” Potential nonmedication treatments and solutions include changes to the diet, increased family support, therapy, and physical activity. HHS also noted that the strategy will include a greater emphasis on education and outreach, along with increased research into this area of study.

Dr. Theresa Miskimen Rivera, president of the American Psychiatric Association, said that her group supports the HHS plans to invest more in research and clinical training. However, she raised concerns about the "framing of mental health as a primary problem of overmedicalization.” Rivera said that "this type of characterization really oversimplifies a very complex, larger issue.”

Addressing the Large Gaps in Mental Health Care

Critics of the Trump administration's plans to emphasize the issue of overprescribing note that the approach is unbalanced when considering that a large portion of the world's population does not have access to mental health care. Depression is distinguished as being the leading cause of disability in the U.S. and the world. However, only about 40% of American adults and adolescents with depression in the U.S. are receiving therapy for these issues. The percentage is even smaller when looking at adults who take prescribed medication designed to treat depression and anxiety.

Rivera addressed this issue specifically, detailing that care for mental health issues in the U.S. “remains unevenly distributed.” She also noted that “This oversimplification of our mental health does not take into account things like persistent workforce shortages, limited psychiatric beds, inadequate visit time, barriers to psychotherapy and social support, and insufficient integration of psychiatric expertise in primary care.”

Some experts warn that it is important not to stigmatize mental health concerns by reducing access to those who could truly use the treatment. Instead, a better strategy would be to invest more money into research that helps to identify what types of treatments could be used as an alternative to prescribed medications.

It should also be noted that quitting medications on your own could have devastating consequences. These decisions should be made in consultation with your physician.

Curious for more stories that keep you informed and entertained? From the latest headlines to everyday insights, YourLifeBuzz has more to explore. Dive into what’s next.